The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Mark A. Hlatky

Stanford University School of Medicine

Stanford

CA 94305

USA

[email]@stanford.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Stanford University School of Medicine, Stanford, CA 94305, USA. 1998 - 2013

References

  1. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study. Hlatky, M.A., Boothroyd, D.B., Baker, L., Kazi, D.S., Solomon, M.D., Chang, T.I., Shilane, D., Go, A.S. Ann. Intern. Med. (2013) [Pubmed]
  2. The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Hlatky, M.A., Chung, S.C., Escobedo, J., Hillegass, W.B., Melsop, K., Rogers, W., Brooks, M.M. Am. Heart J. (2010) [Pubmed]
  3. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Hlatky, M.A., Boothroyd, D.B., Melsop, K.A., Kennedy, L., Rihal, C., Rogers, W.J., Venkitachalam, L., Brooks, M.M. Circulation (2009) [Pubmed]
  4. The year in epidemiology, health services research, and outcomes research. Hlatky, M.A., Heidenreich, P.A. J. Am. Coll. Cardiol. (2009) [Pubmed]
  5. The year in epidemiology, health services research, and outcomes research. Hlatky, M.A., Heidenreich, P. J. Am. Coll. Cardiol. (2009) [Pubmed]
  6. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Hlatky, M.A., Ashley, E., Quertermous, T., Boothroyd, D.B., Ridker, P., Southwick, A., Myers, R.M., Iribarren, C., Fortmann, S.P., Go, A.S. Am. Heart J. (2007) [Pubmed]
  7. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Hlatky, M.A., Quertermous, T., Boothroyd, D.B., Priest, J.R., Glassford, A.J., Myers, R.M., Fortmann, S.P., Iribarren, C., Tabor, H.K., Assimes, T.L., Tibshirani, R.J., Go, A.S. Am. Heart J. (2007) [Pubmed]
  8. The high cost of implantable defibrillators. Hlatky, M.A., Mark, D.B. Eur. Heart J. (2007) [Pubmed]
  9. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease. Hlatky, M.A., Melsop, K.A., Boothroyd, D.B. Am. J. Cardiol. (2006) [Pubmed]
  10. Cost-effectiveness as an outcome in randomized clinical trials. Hlatky, M.A., Owens, D.K., Sanders, G.D. Clin. Trials (2006) [Pubmed]
  11. Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Hlatky, M.A., Sanders, G.D., Owens, D.K. Health. Aff. (Millwood) (2005) [Pubmed]
  12. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Hlatky, M.A., Boothroyd, D.B., Melsop, K.A., Brooks, M.M., Mark, D.B., Pitt, B., Reeder, G.S., Rogers, W.J., Ryan, T.J., Whitlow, P.L., Wiens, R.D. Circulation (2004) [Pubmed]
  13. Cost-effectiveness of the implantable cardioverter defibrillator. Hlatky, M.A., Sanders, G.D., Owens, D.K. Card. Electrophysiol. Rev (2003) [Pubmed]
  14. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. Hlatky, M.A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M.A. JAMA (2002) [Pubmed]
  15. Economic endpoints in clinical trials. Hlatky, M.A. Epidemiol. Rev (2002) [Pubmed]
  16. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995. Hlatky, M.A., Saynina, O., McDonald, K.M., Garber, A.M., McClellan, M.B. Am. Heart J. (2002) [Pubmed]
  17. Economic evaluation in long-term clinical trials. Hlatky, M.A., Boothroyd, D.B., Johnstone, I.M. Stat. Med (2002) [Pubmed]
  18. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Hlatky, M.A., Boothroyd, D.B., Brooks, M.M., Winston, C., Rosen, A., Rogers, W.J., Reeder, G.S., Smith, H.C., Ryan, T.J., Pitt, B., Whitlow, P.L., Wiens, R.D., Mark, D.B. Am. Heart J. (1999) [Pubmed]
  19. Employment after coronary angioplasty or coronary bypass surgery in patients employed at the time of revascularization. Hlatky, M.A., Boothroyd, D., Horine, S., Winston, C., Brooks, M.M., Rogers, W., Pitt, B., Reeder, G., Ryan, T., Smith, H., Whitlow, P., Wiens, R., Mark, D.B. Ann. Intern. Med. (1998) [Pubmed]
 
WikiGenes - Universities